FeesSafety
Pluang+
Home/Explore/US Market Price/Stocks/RMD
icon
Us company
Asset icon - trade crypto, stocks, and gold on Pluang

ResMed Inc. (RMD) Stock Price Today

TechnicalsFundamentalsFinancialsNewsCorp ActionAboutCompare
24H
1W
1M
3M
YTD
1Y
5Y

Aura AI Summary

ResMed (RMD) trades at $252.86, down 0.08% on the day, with a bullish technical signal from moving averages but overbought RSI readings. The company reported strong earnings beats in recent quarters, with Q2 2026 EPS of $2.95 beating estimates of $2.89, and maintains robust profitability with a net income margin of 26.94%. Recent news highlights management's presentation at the Morgan Stanley Healthcare Conference and an upcoming Q1 2027 earnings report on October 29, 2026.
The outlook remains positive given consistent earnings outperformance and projected 12-14% EPS growth, though risks include competitive pressures and ongoing legal investigations. Analyst consensus is mixed with a $243.56 price target below the current price, indicating potential near-term consolidation before further upside driven by fundamental strength.
Read full analysis

Key Stats

  • Market Cap
    $35.61B
  • Volume
    1,048,694
  • Sector
    Health
  • 52W High
    $275.96
  • 52W Low
    $182.82
  • Typical Hold Time
    52 Days
  • Enterprise Value
    $34.97B
  • Div Yield
    1.04%
  • Trading Activity
    100% Sell | 0% Buy
$249.95
52W Low: $182.82
02 Jun 2026
52W High: $275.96
09 Feb 2026

Track ResMed Inc. (RMD) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, ResMed Inc. has traded between a low of $182.82 and a high of $275.96, highlighting its annual price range. Buy and sell ResMed Inc. shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.

About ResMed Inc.

ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payer in the out-of-hospital setting.

Most Recent News

Content is generated by Aura AI

Defense contractors must review CUI access before licensing Microsoft 365 Copilot in GCC High cloud.

eSoftware Associates advises defense contractors to carefully map controlled unclassified information (CUI) access permissions before licensing Microsoft 365 Copilot in the GCC High cloud environment. Moving to GCC High does not automatically grant c...

Market News
1 hour ago
Esoftware Associates
Neutral
Defense contractors must review CUI access before licensing Microsoft 365 Copilot in GCC High cloud.

Eviden launches ASTRA-LAS, a tactical aid system enhancing naval decision-making with AI and real-time data.

Eviden, part of Atos Group, has introduced ASTRA-LAS, a new AI-powered tactical assistant designed to support naval operations by providing enhanced visualizations, automated analyses, and mission-specific recommendations. This system helps naval off...

Market News
3 hours ago
Eviden/Atos Group
Bullish
news icon
Eviden launches ASTRA-LAS, a tactical aid system enhancing naval decision-making with AI and real-time data.

Investec Bank discloses share dealings for Pollen Street Group on October 26, 2026.

Investec Bank plc, acting as joint broker for Pollen Street Group Limited, disclosed share transactions on October 26, 2026. The bank purchased and sold 20,765 ordinary shares at prices ranging from 929 to 935 per share. There were no derivative tran...

Market News
3 hours ago
Na
Neutral
Investec Bank discloses share dealings for Pollen Street Group on October 26, 2026.
Catch up fast with Aura AI
Get an AI-generated news summary for this asset in seconds.

People also bought

Frequently Asked Questions

US stocks trading hours: Monday - Friday (Except for US public holidays) Time: 21.30 - 04.00 WIB 20.30 - 03.00 WIB (Daylight Savings Time*) *The next Daylight Savings is scheduled to begin on March 13, 2022 and ends on November 6, 2022. You can place limit orders outside of the trading hours, but it can only be executed during trading hours. For illustration, a stock is currently trading at $10 per share, but you only want to pay $7 per share at most. Let’s say you set your limit price to $7 at 18.00. Your order will be executed when the market is open at 21.30 if the stock drops from $10 to $7 or lower. Similarly, if the stock price doesn’t drop to $7, your order won’t be executed.
Yes, you are eligible to receive dividend payment if and when the company pays them on one condition: minimum net dividend paid is at least $0.01. Net dividend is gross dividend subtracted by 15% withholding tax.
Yes, it is. US Stocks risk is managed by PT PG Berjangka which is licensed by Badan Pengawas Perdagangan Berjangka Komoditi (BAPPEBTI), and your investment is guaranteed by Jakarta Futures Exchange (JFX) and Indonesian Clearing House (KBI).
Pluang charges a fixed transaction fee of 0.30% for regular users and 0.20% for Pluang Plus members, including VAT to cover the exchange fees and operational costs.
US Stocks, ETFs, and Options are facilitated by PT PG Berjangka in its capacity as a Licensed Derivatives Broker supervised by the Financial Services Authority of Indonesia (OJK) for financial derivative products with underlying securities. All transactions are recorded on the Jakarta Futures Exchange (JFX) and the Indonesian Futures Clearing House (KBI). In addition, PT PG Berjangka is also a Licensed Futures Broker supervised by the Commodity Futures Trading Regulatory Agency (Bappebti). Read our product’s Terms and Conditions

All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.

Key Stats

  • Market Cap
    $35.61B
  • Volume
    1,048,694
  • Sector
    Health
  • 52W High
    $275.96
  • 52W Low
    $182.82
  • Typical Hold Time
    52 Days
  • Enterprise Value
    $34.97B
  • Div Yield
    1.04%
  • Trading Activity
    100% Sell | 0% Buy
$249.95
52W Low: $182.82
02 Jun 2026
52W High: $275.96
09 Feb 2026

Track ResMed Inc. (RMD) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, ResMed Inc. has traded between a low of $182.82 and a high of $275.96, highlighting its annual price range. Buy and sell ResMed Inc. shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.

Let’s invest in this asset by signing up or download!